South Florida Surgical Oncology, part of the GenesisCare network

South Florida Surgical Oncology, part of the GenesisCare network, is a specialized institution located at 18308 Murdock Circle, Port Charlotte, Florida, United States. Led by renowned surgeons such as Dr. Mark Bloomston, MD, FACS, Dr. Bassan J. Allan, MD, and Dr. Catalina Mosquera, MD, the institution focuses on the surgical management of cancers and other tumors, particularly diseases of the liver, bile ducts, and pancreas.

The team at South Florida Surgical Oncology is dedicated to providing expert care and personalized treatment options for patients facing complex and challenging cases. With a focus on advanced surgical procedures, including robotic and laparoscopic surgery, the institution aims to offer the latest in cancer treatment while ensuring the best possible outcomes for their patients.

Through their expertise and commitment to patient care, the team at South Florida Surgical Oncology has helped numerous individuals overcome cancer and return to enjoying life. Their dedication to providing comprehensive care, from diagnosis to treatment and survivorship, sets them apart as leaders in the field of surgical oncology.

With a focus on patient education and support, South Florida Surgical Oncology is committed to empowering patients with the knowledge and resources they need to make informed decisions about their health. Whether discussing risk factors for pancreatic cancer or exploring treatment options for liver diseases, the team is dedicated to providing compassionate care and support at every step of the journey.

As a part of the GenesisCare network, South Florida Surgical Oncology is at the forefront of cancer care, offering innovative treatment options and cutting-edge research opportunities for patients in Southwest Florida. Through their partnership with Lee Health and the Florida Center for Pancreas Diseases, the institution is leading the way in advancing the field of surgical oncology and improving outcomes for individuals facing cancer.